Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

2(66.7%)

N/A

1(33.3%)

3Total

Phase 3(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03674255Enrolling By Invitation

Echocardiography: Value and Accuracy at REst and STress

Role: collaborator

NCT03664700Terminated

Observational Study of the LMA Protector

Role: collaborator

NCT03231007Completed

Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study

Role: collaborator

NCT02216383Phase 3Completed

Intramuscular Oxytocics: A Randomised Control Trial

Role: collaborator

NCT02881411Not ApplicableCompleted

Self Soft Tissue Therapy for Fibromyalgia Syndrome

Role: collaborator

NCT00960466Phase 3Completed

Distress Thermometer Intervention Trial

Role: collaborator

NCT00969189Terminated

Evaluation of the Pediatric Igel Airway in 250 Children

Role: collaborator

All 7 trials loaded